Review Article

Electrical Stimulation Promotes Stem Cell Neural Differentiation in Tissue Engineering

Table 1

iPSCs and ESCs used in clinical trials for the treatment of nerve diseases.

Cell type/goalSourceDiseasePhaseTrail number

Oligodendrocyte progenitor cellHuman brainDemyelinating diseasesUnknownNCT00283023
Human ESC-derived neural precursor cellsHuman embryonic stem cellsParkinson’s diseasePhase 2NCT03119636
Development of iPSCsSomatic cells of patients with neurological diseasesNeurodegenerative disordersRecruitingNCT00874783
Generate disease-specific iPSC linesNeuro-degenerative disease patientsNeuro-degenerative diseaseRecruitingNCT03322306
Establishing of neuronal-like cells from iPSCsPBMCsPeripheral nervous system diseasesWithdrawn (lack of funding)NCT02492360
Neurons and glia derived from iPSCsPatients with genetic mutations responsible for neurological and neurodegenerative diseasesNeurodegenerative diseasesNot yet recruitingNCT03682458
Develop human iPSCsAn existing collection of human somatic cellsAmyotrophic lateral sclerosisRecruitingNCT00801333
Establishment of human cellular disease models from iPSCsPatient-derived fibroblastsWilson diseaseRecruitingNCT03867526
Neuronal distinction of iPSCHuman fibroblast with MYT1L mutationMental retardationCompletedNCT02980302
Neuronal progenitors derived from iPSCBlood sampleRare intellectual disabilitiesRecruitingNCT03635294
Neural cells derived from iPSCPatients’ skinNiemann-pick diseasesRecruitingNCT03883750
Establish an iPSC bankPatients with NF1 mutationsTumors in the central nervous systemSuspendedNCT03332030
Derivation of iPSCHuman somatic cells from existing collectionsAmyotrophic lateral sclerosisRecruitingNCT00801333
Creation of a large repository of iPSCBlood and spinal fluid (optional)Amyotrophic lateral sclerosisCompletedNCT02574390
Creation of a Bank of Fibroblast from iPSCSkin biopsyAmyotrophic lateral sclerosisCompletedNCT01639391
Development of iPSCPatients’ fibroblastNeurodegenerative disordersRecruitingNCT00874783